CERALIS 5.4
COMPOSITION:
Each tablet contains:
Oclacitinib 5.4 mg
INDICATIONS:
It is indicated for the treatment of pruritus associated with allergic dermatitis and for the control of clinical manifestations of atopic dermatitis.
- Description
- Additional information
Description
COMPOSITION:
Each tablet contains:
Oclacitinib 5.4 mg
INDICATIONS:
It is indicated for the treatment of pruritus associated with allergic dermatitis and for the control of clinical manifestations of atopic dermatitis.
Additional information
| Therapeutic Category | |
|---|---|
| Pharmaceutical Form | |
| Species |
